2025 SFGI | Neoadjuvant vs Adjuvant Therapy for Resectable Pancreatic Cancer

2025 SFGI | Neoadjuvant vs Adjuvant Therapy for Resectable Pancreatic Cancer

Overview

NA

Target Audience

NA

This material is non‑CME, no credits are available, and a certificate will not be provided upon completion.

Faculty

Gulam Manji, MD

Date of Release

May 14th, 2025